Skip to Main Content

Paper Details

Predictors of response for elagolix with add-back therapy in women with heavy menstrual bleeding associated with uterine fibroids.
Am J Obstet Gynecol
17
2021
Elagolix, Uterine, Uterine Fibroids, Uterine fibroids, amenorrhea, elagolix, estradiol, fibroid, fibroids, gonadotropin-releasing hormone receptor, gonadotropins, heavy menstrual bleeding, neoplasms, norethindrone acetate, participants, pituitary gonadotropin-releasing hormone receptor, uterine fibroid, uterine fibroids, women
Author NameAffiliation
Kurt T BarnhartUniversity of Pennsylvania
David F ArcherEastern Virginia Medical School
James A SimonGeorge Washington University
  • 1 - 3

Datasets

Release 1.2